VIVO Cannabis Inc.: VIVO Cannabis Announces Third Quarter 2022 Results

Net revenue for Q3 2022 was $6.2 million, a 19% increase from prior quarterInternational sales reach $2.5 million Beacon Medical continues to be the leading medical cannabis flower brand in AustraliaThe

Related Keywords

Germany ,Australia ,United Kingdom ,Vancouver ,British Columbia ,Canada ,Toronto ,Ontario ,Moncton ,New Brunswick ,Spain ,Napanee ,Australian ,Canadian ,British ,German ,Michael Bumby ,Instagram ,Linkedin ,Twitter ,Patient Care Team ,Overdose Prevention Society ,International Pharmaceutical Federation ,Company Vanluven ,Newsfile Corp ,Cannabis Inc ,Facebook ,Health Canada ,Company Adjusted ,High Hopes Foundation ,World Congress ,Downtown East Side ,Supplemental Indenture ,Canna Farms ,Harvest Medicine ,Canna Farm ,Beacon Medical ,Chief Financial ,Forward Looking Information ,Vivo ,Cannabis ,Nnounces ,Third ,Quarter ,022 ,Results ,